| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/09/2011 | WO2011076216A3 Wound care products |
| 09/09/2011 | WO2011062903A9 Slow infusion of sulcardine and its salts |
| 09/09/2011 | WO2011056667A3 Rosacea topical skin treatment method and formulation |
| 09/09/2011 | WO2011051971A3 Solid dispersion of rifaximin |
| 09/09/2011 | WO2011049958A3 Modulation of gel temperature of poloxamer-containing formulations |
| 09/09/2011 | WO2011049954A3 Compositions comprising wnt modulators or neurotoxins for the treatment of otic disorders |
| 09/09/2011 | WO2011041542A3 Herbal pain killer compositions |
| 09/09/2011 | WO2010146409A3 Nanoparticulate candesartan cilexetil compositions, process for the preparation thereof and pharmaceutical compositions containing them |
| 09/09/2011 | DE202011050666U1 Steril verpacktes, saugfähiges, Povidon-lod aufweisendes Trägermaterial Packaged sterile, absorbent, povidone-iodine exhibiting substrate |
| 09/09/2011 | CA2829180A1 A novel composition of matter for delivering lipid-soluble materials, and a method for producing it |
| 09/09/2011 | CA2828041A1 Methods and compositions for treating or preventing symptoms of hormonal variations |
| 09/09/2011 | CA2811091A1 A method for inhibiting alternative pathway mediated disorders with anti-properdin antibodies that inhibit c5 interactions with properdin |
| 09/09/2011 | CA2792171A1 Compositions and methods for treating parasitic disease |
| 09/09/2011 | CA2792046A1 Modified release dosage form |
| 09/09/2011 | CA2792035A1 Compositions and methods for treating or preventing immuno-inflammatory disease |
| 09/09/2011 | CA2791661A1 Mucosal vaccines |
| 09/09/2011 | CA2791561A1 Dabigatran etexilate-containing oral pharmaceutical composition |
| 09/09/2011 | CA2791526A1 Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient |
| 09/09/2011 | CA2791386A1 Controlled delivery system |
| 09/09/2011 | CA2790652A1 Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation |
| 09/09/2011 | CA2790143A1 Solid composition for the oral administration of dyes and diagnostic use thereof |
| 09/09/2011 | CA2790097A1 Nutraceutical chocolate or compound chocolate product |
| 09/09/2011 | CA2787123A1 Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect |
| 09/09/2011 | CA2784819A1 Method of treating parkinson's disease |
| 09/09/2011 | CA2754839A1 Pharmaceutical composition comprising levamlodipine and chlorthalidone |
| 09/08/2011 | US20110219462 G-Protein Coupled Receptor 30 (GPR30) transgenic animals as a model for cardiovascular diseases |
| 09/08/2011 | US20110218506 Amorolfine patch for the treatment of onychomycosis |
| 09/08/2011 | US20110218195 Methods and compositions for treating bacterial infections and diseases associated therewith |
| 09/08/2011 | US20110218102 Dispersable potash granule |
| 09/08/2011 | US20110217448 Method for preparation of a controlled release system |
| 09/08/2011 | US20110217384 Modified Release Dosage Forms of Skeletal Muscle Relaxants |
| 09/08/2011 | US20110217383 Ph-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol |
| 09/08/2011 | US20110217382 Methods and Compositions for Treating Pain Comprising a Statin |
| 09/08/2011 | US20110217381 Pharmaceutical compositions |
| 09/08/2011 | US20110217380 Proteins that stimulate the secretion of satiety hormones |
| 09/08/2011 | US20110217379 Magnetic nanomaterials and methods for chemoembolisation |
| 09/08/2011 | US20110217378 Immobilization of bioactive molecules within a polymeric substrate |
| 09/08/2011 | US20110217377 Long Circulating Nanoparticles for Sustained Release of Therapeutic Agents |
| 09/08/2011 | US20110217376 Poly(amidoamine) oligomer hydrogel for drug delivery and drug carrier using the same |
| 09/08/2011 | US20110217375 Dendrimeric peptides, pharmaceutical compositions and methods of using the same |
| 09/08/2011 | US20110217374 pharmaceutical composition simultaneously having rapid-acting property and long-acting property |
| 09/08/2011 | US20110217373 Extended release pharmaceutical compositions of guanfacine hydrochloride |
| 09/08/2011 | US20110217372 Fast dissolving oral tablets and method for production thereof |
| 09/08/2011 | US20110217371 Controlled-release microparticles and method of preparing same |
| 09/08/2011 | US20110217370 Substances for promoting healthy joint function comprising glucosamine sulfate, omega-3 polyunsaturated fatty acids or derivatives thereof, and undenatured type ii collagen |
| 09/08/2011 | US20110217369 Fenofibrate compositions |
| 09/08/2011 | US20110217368 Bacterial compositions for prophylaxis and treatment of degenerative disease |
| 09/08/2011 | US20110217367 Means for inhibiting the expression of orc-1 |
| 09/08/2011 | US20110217366 Immunopotentiating composition |
| 09/08/2011 | US20110217365 Compositions and Methods for Gene Silencing |
| 09/08/2011 | US20110217364 Conjugated suramin amino compounds for medical conditions |
| 09/08/2011 | US20110217363 Two-step targeted tumor therapy with prodrug encapsulated in nanocarrier |
| 09/08/2011 | US20110217362 Group of Nucleic Acid Fragments for Prevention of HIV Infection or AIDS and the Usage Thereof |
| 09/08/2011 | US20110217361 Group of Nucleic Acid Fragments for Prevention of HIV Infection or AIDS and the Usage Thereof |
| 09/08/2011 | US20110217360 Octenidine composition |
| 09/08/2011 | US20110217359 Pharmaceutical composition for the prophylactic or therapeutic treatment of decubiti and first degree burns and treatment method |
| 09/08/2011 | US20110217358 Compositions for the prophylaxis and treatment of dermatological/mucosal diseases, and uses thereof |
| 09/08/2011 | US20110217357 Method for solubilizing metronidazole |
| 09/08/2011 | US20110217356 Controlled delivery system |
| 09/08/2011 | US20110217354 Implants for administering substances and methods of producing implants |
| 09/08/2011 | US20110217353 Implants for administering substances and methods of producing implants |
| 09/08/2011 | US20110217350 Substrate having a surface for inhibiting adhesion of a target cell thereon and a method of preparing the same |
| 09/08/2011 | US20110217346 Emulsion containing organosilicon-based portions of hollow spheres |
| 09/08/2011 | US20110217344 Spermicidal and virucidal properties of various forms of sophorolipids |
| 09/08/2011 | US20110217343 Hydrolytically degradable alkylene oxide based polymers |
| 09/08/2011 | US20110217342 Flashmelt oral dosage formulation |
| 09/08/2011 | US20110217341 Method for preparing microspheres and microspheres produced thereby |
| 09/08/2011 | US20110217340 nanodisperse compositions |
| 09/08/2011 | US20110217339 Mucoactive agents for treating a pulmonary disease |
| 09/08/2011 | US20110217338 HIV-1 Envelope Based Fragments |
| 09/08/2011 | US20110217337 Bioactive agent for bone tissue engineering |
| 09/08/2011 | US20110217336 Chronotherapeutic dosage forms and methods of treatment using chronotherapy |
| 09/08/2011 | US20110217335 Synthesis of resorcylic acid lactones useful as therapeutic agents |
| 09/08/2011 | US20110217289 Melt-Coated Dosage Forms |
| 09/08/2011 | US20110217283 Stable galenic freeze-dried pharmaceutical preparation of recombinant carbohydrate-binding polypeptides |
| 09/08/2011 | US20110217236 Radiation sensitive liposomes |
| 09/08/2011 | US20110216622 Liposomal apparatus and manufacturing method |
| 09/08/2011 | DE102010002604A1 Capsule, useful for receiving a medium, preferably medical preparations, comprises a capsule lower part with an outwardly curved, inner hollow ridge to incorporate a medium, and a capsule upper part attached on capsule lower part |
| 09/07/2011 | EP2363479A1 Oligoribonucucleotide for inhibiting the expression of a predefined gene |
| 09/07/2011 | EP2363424A1 Block copolymers for multifunctional self-assembled systems |
| 09/07/2011 | EP2363151A1 Poly(amidoamine) oligomer hydrogel for drug delivery and drug carrier using the same |
| 09/07/2011 | EP2363150A1 Compositions and methods for enhancing corticosteroid delivery |
| 09/07/2011 | EP2363145A1 Pharmaceutical anti-TNF-alpha antibody formulation |
| 09/07/2011 | EP2363144A1 Pharmaceutical anti-TNF-alpha antibody formulation |
| 09/07/2011 | EP2363122A1 Clonidine to treat pain locally |
| 09/07/2011 | EP2363121A1 Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor agonist for the treatment of inflammatory and allergic conditions |
| 09/07/2011 | EP2363118A1 Gum resin as a carrier for topical application of pharmacologically active agents |
| 09/07/2011 | EP2363117A1 Drug delivery systems comprising weakly basic selective serotonin 5-HT3 blocking agent and organic acids |
| 09/07/2011 | EP2363116A1 Sustained-release formulations comprising lofexidine for oral delivery |
| 09/07/2011 | EP2363115A2 Complexation of metal ions with polypeptides |
| 09/07/2011 | EP2363114A1 Sustained release of antiinfectives |
| 09/07/2011 | EP2363113A1 Enhanced immediate release formulations of topiramate |
| 09/07/2011 | EP2363112A2 Osmotic delivery systems and piston assemblies |
| 09/07/2011 | EP2363111A1 Stable pharmaceutical composition comprising bisphosphonate |
| 09/07/2011 | EP2363108A1 Foam formulation containing at least one triterpenoid |
| 09/07/2011 | EP2363104A1 Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| 09/07/2011 | EP2362777A1 Use of pharmaceutical compositions in preparing pharmaceuticals for treating diabetic ulcer |
| 09/07/2011 | EP2362769A2 Gold nanoparticles coated with polyelectrolytes and albumin |
| 09/07/2011 | EP2362768A1 Extended release oral acetaminophen/tramadol dosage form |
| 09/07/2011 | EP2362767A2 Formulations of single domain antigen binding molecules |